These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Multiple-dose pharmacokinetics of intravenous telavancin in healthy male and female subjects. Wong SL, Barriere SL, Kitt MM, Goldberg MR. J Antimicrob Chemother; 2008 Oct; 62(4):780-3. PubMed ID: 18586659 [Abstract] [Full Text] [Related]
26. Population pharmacokinetics of aminoglycosides in critically ill trauma patients on once-daily regimens. Barletta JF, Johnson SB, Nix DE, Nix LC, Erstad BL. J Trauma; 2000 Nov; 49(5):869-72. PubMed ID: 11086778 [Abstract] [Full Text] [Related]
36. Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients. Fuhs DW, Mann HJ, Kubajak CA, Cerra FB. Clin Pharm; 1988 Mar; 7(3):207-13. PubMed ID: 3356116 [Abstract] [Full Text] [Related]
37. [The role of the phenomenon of the redistribution of aminoglycosides in their monitoring and dosage calculation in patients in the terminal stage of kidney failure undergoing systematic hemodialysis treatment]. Siniukhin VN, Darenkov AF, Stetsiuk EA, Nikolaeva NP, Iarmolinskiĭ IS. Urol Nefrol (Mosk); 1991 Mar; (1):43-7. PubMed ID: 1858206 [Abstract] [Full Text] [Related]
38. Outcomes of acute renal failure patients requiring intermittent hemodialysis. Ozturk S, Arpaci D, Yazici H, Taymez DG, Aysuna N, Yildiz A, Sever MS. Ren Fail; 2007 Mar; 29(8):991-6. PubMed ID: 18067046 [Abstract] [Full Text] [Related]